PREVENT ESRD Act
The source supplies the latest action, but no lifecycle stage.
Latest action (22 Jul 2026): Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
What this bill does
H.R. 9891, the PREVENT ESRD Act, directs the Secretary of Health and Human Services to establish a listening session on kidney disease within 180 days of enactment, bringing together clinicians, patients, health plans, and other experts to identify ways to improve early screening and treatment. The bill's main provision creates a 10-year Medicare demonstration program, to begin by January 1, 2027, that allows health plans—including commercial group and individual insurers, Medicaid programs, and Medicare Advantage plans—to voluntarily participate in efforts to prevent chronic kidney disease from progressing to end-stage renal disease (ESRD).
Participating plans would be required to cover specified kidney-related screening, drugs, nutrition support, and disease-management services with minimal cost-sharing, and to submit data on disease progression and outcomes. In return, plans meeting performance benchmarks could receive a share (25 percent) of the resulting Medicare savings, and may also receive advance "investment" payments to support program compliance. The Secretary would monitor and evaluate results, report to Congress at the 3- and 6-year marks, and fund the program through Medicare trust funds.
The bill affects Medicare, Medicaid, and private insurance plans, as well as individuals diagnosed with kidney disease. It was introduced on July 22, 2026, by Rep. Joe Wilson and referred to the House Committees on Energy and Commerce and Ways and Means; no further action has occurred.
Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.
Timeline
22 Jul 2026
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Common questions
- What does H.R. 9891 do?
- H.R. 9891, the PREVENT ESRD Act, directs the Secretary of Health and Human Services to establish a listening session on kidney disease within 180 days of enactment, bringing together clinicians, patients, health plans, and other experts to identify ways to improve early screening and treatment. The bill's main provision creates a 10-year Medicare demonstration program, to begin by January 1, 2027, that allows health plans—including commercial group and individual insurers, Medicaid programs, and Medicare Advantage plans—to voluntarily participate in efforts to prevent chronic kidney disease from progressing to end-stage renal disease (ESRD). Participating plans would be required to cover specified kidney-related screening, drugs, nutrition support, and disease-management services with minimal cost-sharing, and to submit data on disease progression and outcomes. In return, plans meeting performance benchmarks could receive a share (25 percent) of the resulting Medicare savings, and may also receive advance "investment" payments to support program compliance. The Secretary would monitor and evaluate results, report to Congress at the 3- and 6-year marks, and fund the program through Medicare trust funds. The bill affects Medicare, Medicaid, and private insurance plans, as well as individuals diagnosed with kidney disease. It was introduced on July 22, 2026, by Rep. Joe Wilson and referred to the House Committees on Energy and Commerce and Ways and Means; no further action has occurred.
- Has H.R. 9891 become law?
- The source does not supply a confirmed lifecycle stage for H.R. 9891. Check the latest action and official source below.
- Who sponsored H.R. 9891?
- H.R. 9891 was sponsored by Rep. Wilson, Joe [R-SC-2] (R-SC), with 0 cosponsors.
- What's the latest action on H.R. 9891?
- Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. (22 Jul 2026).
Related bills in Health
Choices for Increased Mobility Act of 2026
Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
340B Rebate Model Delay Act
Lower Premiums, Faster Payments Act
More bills from Rep. Wilson, Joe [R-SC-2]
To impose targeted sanctions on the Houthi terrorists and their supporters, and to support the internationally recognized Government of Yemen in their fight against Houthi terrorists.
SRBIJA Act
Recognizing Charleston as the appropriate host city for the 2027 annual meeting of the Organization for Security and Cooperation in Europe Parliamentary Assembly.
Ending Predator Access to Union Power Act
Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.